MENU
PODD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Insulet (PODD) Ownership - Who owns Insulet?
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
100 Nagog Park
Phone
+1 978 600-7000
Employees
3000
Web
https://www.insulet.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
11.75B
P/E Ratio
57.17
Total Cash
704.2M
Projected Growth
3.02
Total Debt
1.42B
Revenue
1.7B
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash/Share
10.07
Total Debt/Equity
100.98
Revenue/Share
23.05 USD as % of share price
Fundamentals
PODD
Capitalization
11.8B
P/E Ratio
57.17
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash
704M
Total Cash/Share
10.07
Total Debt
1.42B
Total Debt/Equity
100.98
Projected Growth (PEG Ratio)
3.02
Revenue/Share (as % of the share price)
23.05%
Revenue
1.7B
ROE
N/A
Book Value
733M
P/B Ratio
16.05
Cash Flow
N/A
Earnings
2.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
3.51
Current Revenue Per Employee
169933.33
Dividends Per Share - Security
N/A
EBITDA
324M
Float
N/A
Float - Current
N/A
Gross Income Margin
70.85
Revenue To Assets
8.53
Shares Held By Institutions
40.7B
Shares Outstanding - Current
69.9M
Total Liabilities
1.86B
Total Volume MTD
N/A
Value
-1
Gain YTD
-1.536
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of insulin infusion systems
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
100 Nagog Park
Phone
+1 978 600-7000
Employees
3000
Web
https://www.insulet.com